Cantor Fitzgerald Forecasts Insmed FY2026 Earnings
Insmed Incorporated (NASDAQ:INSM – Free Report) – Stock analysts at Cantor Fitzgerald issued their FY2026 EPS estimates for shares of Insmed in a research note issued to investors on Monday, June 9th. Cantor Fitzgerald analyst J. Kim forecasts that the biopharmaceutical company will post earnings of ($4.24) per share for the year. Cantor Fitzgerald has […]
